Risk of ESRD and Mortality in Kidney and Bladder Stone Formers

被引:83
|
作者
Dhondup, Tsering [1 ]
Kittanamongkolchai, Wonngarm [1 ]
Vaughan, Lisa E. [2 ]
Mehta, Ramila A. [2 ]
Chhina, Jasdeep K. [2 ]
Enders, Felicity T. [2 ]
Hickson, LaTonya J. [1 ]
Lieske, John C. [1 ]
Rule, Andrew D. [1 ]
机构
[1] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA
[2] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA
基金
美国国家卫生研究院;
关键词
NEPHROLITHIASIS; DISEASE;
D O I
10.1053/j.ajkd.2018.06.012
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Rationale & Objectives: Kidney stones have been associated with increased risk for end-stage renal disease (ESRD). However, it is unclear whether there is also an increased risk for mortality and if these risks are uniform across clinically distinct categories of stone formers. Study Design: Historical matched-cohort study. Setting & Participants: Stone formers in Olmsted County, MN, between 1984 and 2012 identified using International Classification of Diseases, Ninth Revision codes. Age- and sex-matched individuals who had no codes for stones were the comparison group. Predictor: Stone formers were placed into 5 mutually exclusive categories after review of medical charts: incident symptomatic kidney, recurrent symptomatic kidney, asymptomatic kidney, bladder only, and miscoded (no stone). Outcomes: ESRD, mortality, cardiovascular mortality, and cancer mortality. Analytic& Approach: Cox proportional hazards models with adjustment for baseline comorbid conditions. Results: Overall, 65 of 6,984 (0.93%) stone formers and 102 of 28,044 (0.36%) non-stone formers developed ESRD over a mean follow-up of 12.0 years. After adjusting for baseline hypertension, diabetes mellitus, dyslipidemia, gout, obesity, and chronic kidney disease, risk for ESRD was higher in recurrent symptomatic kidney (HR, 2.34; 95% Cl, 1.08-5.07), asymptomatic kidney (HR, 3.94; 95% Cl, 1.65-9.43), and miscoded (HR, 6.18; 95% Cl, 2.25-16.93) stone formers, but not in incident symptomatic kidney or bladder stone formers. The adjusted risk for all-cause mortality was higher in asymptomatic kidney (HR, 1.40; 95% Cl, 1.18-1.67) and bladder (HR, 1.37; 95% Cl, 1.12-1.69) stone formers. Chart review of asymptomatic and miscoded stone formers suggested increased risk for adverse outcomes related to diagnoses including urinary tract infection, cancer, and musculoskeletal or gastrointestinal pain. Conclusions: The higher risk for ESRD in recurrent symptomatic compared with incident symptomatic kidney stone formers suggests that stone events are associated with kidney injury. The clinical indication for imaging in asymptomatic stone formers, the correct diagnosis in miscoded stone formers, and the cause of a bladder outlet obstruction in bladder stone formers may explain the higher risk for ESRD or death in these groups.
引用
下载
收藏
页码:790 / 797
页数:8
相关论文
共 50 条
  • [1] Body Mass Index (BMI) and Kidney Stone Risk in Calcium Kidney Stone Formers
    Tang, Jie
    Bhetuwal, Uttam
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 225 - 225
  • [2] Risk of Chronic Kidney Disease in Brushite Stone Formers Compared With Idiopathic Calcium Oxalate Stone Formers
    Rivera, Marcelino
    Jaeger, Chris
    Yelfimov, Daniel
    Krambeck, Amy E.
    UROLOGY, 2017, 99 : 23 - 26
  • [3] Increased ESRD and mortality risk for kidney donors?
    Arthur J. Matas
    Nature Reviews Nephrology, 2014, 10 : 130 - 131
  • [4] The impact of kidney stone disease on quality of life in high-risk stone formers
    Assad, Anis
    Raizenne, Brendan L.
    El Yamani, Mohammed El Mehdi
    Saud, Almousa
    Bechis, Seth K.
    Sur, Roger L.
    Nakada, Stephen Y.
    Streeper, Necole M.
    Sivalingam, Sri
    Pais, Vernon M.
    Chew, Ben H.
    Bird, Vincent G.
    Andonian, Sero
    Penniston, Kristina L.
    Bhojani, Naeem
    BJU INTERNATIONAL, 2024, 133 (05) : 570 - 578
  • [5] The impact of kidney stone disease on quality of life in high-risk stone formers
    Assad, A.
    Raizenne, B.
    El-Yamani, M. E. M.
    Almousa, S.
    Bechis, S. K.
    Sur, R. L.
    Nakada, S. Y.
    Streeper, N. M.
    Pais, V. M., Jr.
    Sivalingam, S.
    Chew, B. H.
    Andonian, S.
    Bhojani, N.
    EUROPEAN UROLOGY, 2024, 85 : S768 - S770
  • [6] Ectopic biomineralization in kidney stone formers compared to non-stone formers
    Fernandez, Adrian M.
    Sherer, Benjamin A.
    Gansky, Stuart A.
    Mena, Jorge D.
    Srirangapatanam, Sudarshan
    Wiener, Scott, V
    Chi, Thomas
    Ho, Sunita P.
    Stoller, Marshall L.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (05) : 2129 - +
  • [7] Chronic Kidney Disease in Kidney Stone Formers
    Rule, Andrew D.
    Krambeck, Amy E.
    Lieske, John C.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (08): : 2069 - 2075
  • [8] THE IMPACT OF KIDNEY STONE DISEASE ON QUALITY OF LIFE IN HIGH-RISK STONE FORMERS
    Assad, Anis
    Raizenne, Brendan L.
    El Yamani, Mohamed E. M.
    Almousa, Saud
    Bechis, Seth K.
    Sur, Roger L.
    Nakada, Stephen Y.
    Streeper, Necole M. M.
    Sivalingam, Sri
    Pais, Vernon M.
    Chew, Ben H.
    Bird, Vincent G.
    Andonian, Sero
    Penniston, Kristina L.
    Bhojani, Naeem
    JOURNAL OF UROLOGY, 2024, 211 (05): : E745 - E745
  • [9] TRANSPLANTATION Increased ESRD and mortality risk for kidney donors?
    Matas, Arthur J.
    NATURE REVIEWS NEPHROLOGY, 2014, 10 (03) : 130 - 131
  • [10] RISK OF UTI IN KIDNEY STONE FORMERS: A MATCHED-COHORT STUDY
    Geraghty, Robert
    Walker, Valerie
    Paul, Cook
    Roderick, Paul
    Somani, Bhaskar
    JOURNAL OF UROLOGY, 2020, 203 : E25 - E25